¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"visual directive line"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • visual analogue scale
    ½Ã°¢¾Æ³¯·Î±×ôµµ, ½Ã°¢ÅëÁõµî±Þ
  • visual angle
    ½Ã°¢°¢
  • visual aphasia
    ½Ã°¢¾ð¾î»ó½ÇÁõ, ½Ã°¢½Ç¾îÁõ
  • visual area
    ½Ã°¢¿µ¿ª
  • visual association area
    ½Ã°¢¿¬ÇÕ¿µ¿ª
  • visual aura
    ½Ã°¢Á¶Áü
  • visual axis
    ½Ã¼±Ãà, ½ÃÃà
  • visual cell
    ½Ã°¢¼¼Æ÷
  • visual center
    ½Ã°¢ÁßÃß
  • visual cone
    ½Ã°¢¿ø»Ô
  • visual confusion
    ½Ã°¢È¥¶õ
  • visual cortex
    ½Ã°¢°ÑÁú, ½Ã(°¢)ÇÇÁú
  • visual defect
    ½Ã(°¢)°á¼Õ
  • visual deprivation
    ½Ã°¢¹ÚÅ»
  • visual discrimination
    ½Ã°¢½Äº°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • visual memory
    ½Ã°¢±â¾ï
  • visual pathway
    ½Ã°¢°æ·Î
  • visual acuity test
    ½Ã·Â°Ë»ç
  • visual
    ½Ã·Â-, ½Ã°¢-
  • stereoscopic visual
    ÀÔü½Ã
  • visual window
    ½Ã¾ßâ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • visual projection area
    ½Ã°¢Åõ»ç±¸¿ª
  • complex visual discrimination
    º¹Çսð¢ºÐº°
  • visual cell
    ½Ã°¢¼¼Æ÷
  • visual center
    ½Ã°¢ÁßÃß
  • visual cone
    (¢¡ocular cone) ½Ã°¢¿ø»Ô
  • visual confusion
    ½Ã°¢È¥¶õ
  • visual cortex
    ½Ã°¢°ÑÁú, ½Ã°¢ÇÇÁú
  • visual acuity test chart
    ½Ã·Â°Ë»çÇ¥
  • visual defect
    ½Ã°¢°á¼Õ
  • visual deprivation
    ½Ã°¢Â÷´Ü
  • visual discrimination
    ½Ã°¢½Äº°
  • visual disturbance
    ½Ã·ÂÀå¾Ö, ½Ã°¢Àå¾Ö
  • visual field defect
    ½Ã¾ß°á¼Õ
  • visual efficiency
    ½Ã°¢È¿À²
  • visual field examination
    ½Ã¾ß°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Kerley s A line
    Äø® A¼±.
  • Kerley s B line
    Äø® B¼±.
  • Kerley s C line
    Äø® C¼±.
  • Kerleys A line
    Äø® A¼±
  • Kerleys B line
    Äø® B¼±
  • Kerleys C line
    Äø® C¼±
  • Kerleys D line
    Äø® D¼±
  • Langer line
    ¶û°Å¼±
  • Mees line
    ¹ÌÁî¼±
  • Sampaolesis line
    »ïÆú·¹½Ã»ö¼Ò¼±
  • Staehlis line
    ½ºÅÚ¸®¼±
  • Stocker line
    ½ºÅåÄ¿¼±
  • Vogts line
    º¸Å©Æ®¼±
  • Voigt line
    Æ÷ÀÌÆ®¼±
  • Z line(=disc)
    Z¼± (ÆÇ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • optic agnosia =visual agnosia
    ½Ã°¢½ÇÀÎÁõ(ãÊÊÆã÷ìãñø).
  • optic aphasia =visual a.
    ½Ã°¢¼º ½Ç¾î(Áõ)(ãÊÊÆàõã÷åÞñø).
  • organic visual loss
    ±âÁú½Ã°¢»ó½Ç
  • peripheral visual field
    ÁÖº¯½Ã¾ß(ñ²Ü«ãÊå¯).
  • red green visual substance
    Àû·Ï(»ö)½Ã°¢ ¹°Áú.
  • retinal visual cells
    ¸Á¸·½Ã¼¼Æ÷
  • rivalry of visual fields
    ½Ã¾ß(ãÊå¯)°æÇÕ.
  • rivaly in the visual field
    ½Ã¾ß°æÇÕ
  • static visual field
    Á¤Àû½Ã¾ß
  • stereoscopic visual acuity
    ÀÔü½Ã·Â
  • visual
    ½Ã·Â(ãÊæ³)ÀÇ, ½Ã°¢(ãÊÊÆ)ÀÇ
  • visual
    ½Ã·Â(ãÊæ³)ÀÇ, ½Ã°¢(ãÊÊÆ)ÀÇ.
  • visual acuity
    ½Ã·Â(ãÊæ³)
  • visual acuity
    ½Ã·Â(ãÊæ³).
  • visual acuity test
    ½Ã·Â°Ë»ç(¡­ËþÞÛ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Highest nuchal line
    ¸ÇÀ§¸ñ´ú¹Ì¼±
    [¿¾ ¿ë¾î] ÃÖ»óÇ×(¸ñ´ú¹Ì)¼±
  • Semilunar line
    ¹Ý´Þ¼±
    [¿¾ ¿ë¾î] ¹Ý¿ù¼±
  • Terminal line
    ºÐ°è¼±
    [¿¾ ¿ë¾î] ºÐ°è¼±
  • Midclavicular line
    ºøÀåÁß°£¼±
    [¿¾ ¿ë¾î] À¯µÎ¼±
  • Epiphyseal line
    »À³¡¼±
    [¿¾ ¿ë¾î] °ñ´Ü¼±
  • Incremental line of dentin
    »ó¾ÆÁú¼ºÀå¼±
    [¿¾ ¿ë¾î] »ó¾ÆÁú¼ºÀå¼±
  • Incremental line of cementum
    ½Ã¸àÆ®Áú¼ºÀå¼±
    [¿¾ ¿ë¾î] ½Ã¸àÆ®Áú¼ºÀå¼±
  • Inferior temporal line
    ¾Æ·¡°üÀÚ¼±
    [¿¾ ¿ë¾î] ÇÏÃøµÎ¼±
  • Inferior nuchal line
    ¾Æ·¡¸ñ´ú¹Ì¼±
    [¿¾ ¿ë¾î] ÇÏÇ×(¸ñ´ú¹Ì)¼±
  • Inferior gluteal line
    ¾Æ·¡º¼±â±Ù¼±
    [¿¾ ¿ë¾î] Çϵбټ±
  • Medial supracondylar line
    ¾ÈÂʰüÀýÀ¶±âÀ§¼±
    [¿¾ ¿ë¾î] ³»Ãø°ú»ó¼±
  • Anterior axillary line
    ¾Õ°Üµå¶û¼±
    [¿¾ ¿ë¾î] Àü¾×¿Í¼±
  • Anterior gluteal line
    ¾Õº¼±â±Ù¼±
    [¿¾ ¿ë¾î] ÀüµÐ±Ù¼±
  • Midsternal line
    ¾ÕÁ¤Áß¼±
    [¿¾ ¿ë¾î] ÀüÁ¤Áß¼±
  • Scapular line
    ¾î±ú»À¼±
    [¿¾ ¿ë¾î] °ß°©¼±
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • line spectrum
    ¼±(àÊ)½ºÆåÆ®·Ò
  • line splitting
    ¼±ºÐÇÒ(àÊÝÂùÜ)
  • pure line
    ¼ø¼ö °èÅë(ͧ÷Ö)
  • regression line
    ȸ±Í¼±(üÞÏýàÊ)
  • T cell line
    T ¼¼Æ÷ÁÖ(á¬øàñ»)
  • Z line
    Z ¼±(àÊ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • growth line
    ¼ºÀå¼±
  • Kerley's A line
    Äø® A¼±
  • Kerley's B line
    Äø® B¼±
  • Kerley's C line
    Äø® C¼±
  • Kerley's D line
    Äø® D¼±
  • line pair/mm
    mm´ç ¼±ÀǼö
  • oblique line
    °æ»ç¼±, »ç¼±
  • off-line
    ¿ÀÇÁ¶óÀÎ
  • O-M [=orbitomeatal] line
    ¾È¿ÜÀ̵µ¼±
  • on-line
    ¿Â¶óÀÎ
  • orbitomeatal [=O-M] line
    ¾È¿ÜÀ̵µ¼±
  • paravertebral line
    ôÃßÁÖÀ§¼±
  • pectineal line
    Ä¡°ñ±Ù¼±
  • prosthesis cement lucent line
    Àΰø¹°½Ã¸àÆ® ¹æ»ç¼ºÅõ°ú¼±
  • reinforcement line
    °­È­¼±
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
IAD inactivating dose; instructional advance directive; internal absorbed dose
CCL carcinoma cell line; certified cell line; Charcot-Leyden crystal; continuing care level; critical ca...
LCL Levinthal-Coles-Lillie [body]; lower confidence limit; lower control limit; lymphoblastoid cell line...
MCL maximum containment laboratory; medial collateral ligament; midclavicular line; midcostal line; mini...
AVC aberrant ventricular conduction; Academy of Veterinary Cardiology; aortic valve closure; associative...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CHO Chinese hamster ovary cell line
FSL Flinder sensitive line
FRL Flinders Resistant Line
FLN Fluorescence Line Narrowing
GDNF GLIAL cell-line derived neurotrophic factor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • visual white
    ½Ã¹é
  • alveolar line
    Ä¡Á¶¼±, »ó¾Ç¼±
  • alveolar ridge line
    Ä¡Á¶Á¤ ¼±
  • base line
    ±â¼±, ±âÀú¼±, ¹ÙÅÁ¼±
    ¹ÌÁ¤ÀÇ ¾çÀ̳ª °ªÀ» ÃøÁ¤ ¶Ç´Â ÆòÁ¤ÇÏ´Â µ¥ ¾²ÀÌ´Â ±âº»ÀÇ ¾ç ¶Ç´Â °ª.
  • base line shift
    ±âÁؼ± º¯À§
  • blood line
    Ç÷Á·, Ç÷Á·°è
  • Camper's line
    įÆÛ ¼±
    ºñÀÍÀÇ Çϴܰú ¿ÜÀ̵¹±âÀÇ »ó¿¬À» ¿¬°áÇÏ´Â ¼±.
  • cell line
    ¼¼Æ÷°è
  • cement line
    ½Ã¸àÆ® ¼±
    Ä¡°ü º¸Ã¶¹°À» Áö´ëÄ¡¿¡ Ä¡°ú¿ë ÇÕÂøÁ¦·Î ¿µ±¸ ÇÕÂø½ÃÄ×À» ¶§ ºÎÁ¤È®ÇÑ Á¢ÇÕÀ¸·Î ÇÕÂøÁ¦°¡ ³ëÃâµÇ´Â °Í.
  • cemental line
    ½Ã¸àÆ® ¼±
    °ñÀÇ È¾´Ü¸éÀÇ Çö¹Ì°æ °Ë»ç¿¡¼­ °üÂûµÇ´Â ¼±. °ñ´ÜÀ§ÀÇ °æ°è¸¦ ³ªÅ¸³½´Ù.
  • cervical line
    °æ¼±, Ä¡°æ¼±
    Ä¡±Ù°ú Ä¡°üÀÇ °æ°è¸¦ Ä¡°æ¼±À̶óÇÏ°í ¹ý¶û, ¹é¾ÇÁú °æ°è ºÎÀ§¸¦ ¶æÇϸç neck lineÀ̶ó°íµµ ÇÑ´Ù. ÀÌ ¼±Àº ¿µ±¸ ºÒº¯ÀÇ ¼±ÀÌ´Ù.
  • curve of dental cervical line
    Ä¡°æ ¼± ¸¸°î
  • double line hemorrhage
    µÎ ÁÙ ÃâÇ÷, Áß¼± ÃâÇ÷
  • facial line
    ¾È¸é ÁÖ¸§, ¾È¸é±¸
  • fulcrum line
    ÁöÁ¡ ¼±, Áö·¿ ¼±
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
visual cycle The transformation of carotenoids involved in the bleaching and regeneration of the visual pigment.
(05 Mar 2000)
visual efficiency A rating used in computing compensation for industrial ocular injuries, incorporating measurements of central acuity, visual field, and ocular motility.
(05 Mar 2000)
visual evoked potential Voltage fluctuations that may be recorded from the occipital area of the scalp as the result of retinal stimulation by a light flashing at 1/4-second intervals; commonly summated and averaged by computer.
(05 Mar 2000)
visual extinction A condition in which individual stimuli are seen correctly, but when the nasal visual field of one eye and the temporal visual field of the fellow eye are stimulated simultaneously, one field is blind.
Synonym: visual extinction.
(05 Mar 2000)
visual field The area simultaneously visible to one eye without movement; often measured by means of a bowl perimeter located 330 mm from the eye.
(05 Mar 2000)
visual field test <ophthalmology> A test which measures the extent of visual field loss. This test may be performed by a number of methods including confrontation, tangent screen exam and automated perimetry.
Diseases that affect visual field include stroke, diabetes, hypertension, multiple sclerosis, glaucoma, hyperthyroidism, Jacob-Creutzfeldt disease and optic glioma.
(27 Sep 1997)
visual image A collection of foci corresponding to all the luminous points of an object.
(05 Mar 2000)
visual orbicularis reflex Contraction of the orbicularis oculi muscle caused by a sudden visual stimulus.
See: wink reflex.
(05 Mar 2000)
visual organ The eye and its adnexa.
Synonym: organum visus, organ of vision.
(05 Mar 2000)
visual pathway Neural paths and connections within the central nervous system, beginning with the retina and terminating in the occipital cortex.
(05 Mar 2000)
visual perception The selecting and organizing of visual stimuli based on the individual's past experience.
(12 Dec 1998)
visual pigments The photopigments in the retinal cones and rods that absorb light and initiate the visual process.
(05 Mar 2000)
visual projection A perceptual synthesis involving visual mechanisms.
(05 Mar 2000)
visual purple <protein> Light sensitive pigment formed from retinal linked through a Schiff's base to opsin: rhodopsin is an integral membrane protein found in the discs of retinal rods and cones, comprising some 40% of the membrane. Vertebrate opsins are proteins of 38 kD.
See: bacteriorhodopsin.
(18 Nov 1997)
visual receptor cells The rod and cone cell's of the retina.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • two-line
    ¹èÇüÀÇ
  • A line
    ¶óÀÎÀÇ;A¶óÀÎÀÇ(¿©¼ºº¹ÀÌ AÀÚó·³ À§°¡ Á¼°í ¹ØÀÌ ÆÛÁü)
  • DEW line
    µà¶óÀÎ(ºÏ±Ø±Ç ºÏºÎ¿¡ ÀÖ´Â ¹Ì±¹.ij³ª´Ù °øµ¿ÀÇ ¿ø°Å¸®Á¶±â °æº¸¸Á)
  • Distant Early Warning line
    =DEW LINE
  • Gray Line
    ¹Ì±¹ÀÇ ´ë±Ô¸ð °ü±¤¹ö½º ȸ»ç
  • International Date Line
    ±¹Á¦ ³¯Â¥ º¯°æ¼±(IDL)
  • Mason Dixon line
    MarylandÁÖ¿Í PennsylvaniaÁÖÀÇ °æ°è¼±(³ë¿¹ ½Ã´ëÀÇ ³²ºÏ °æ°è¼±,ÇöÀç´Â ¹æ¾ð ±¸ºÐ¼±ÀÇ Çϳª)
  • Siegfried Line
    ÁöÅ©ÇÁ¸®Æ®¼±;Á¦ 2Â÷ ´ëÀü¿¡ ¾Õ¼­ µ¶ÀÏÀÌ ±¸ÃàÇÑ ¼­ºÎÀÏ´ëÀÇ ¿ä»õ¼±
  • assembly line
    ÀϰüÀÛ¾÷Á¶Á÷
  • base line
    ±âÁؼ±;´©¼±
  • battle line
    Àü¼±
  • bay line
    ´ëÇǼ±;Ãø¼±
  • belt line
    ¼øÈ¯¼±
  • bread line
    »§¹è±ÞÀ»¹Þ´Â»ç¶÷
  • building line
    (µµ·Î µûÀ§¿¡ ÀÓÇÏ´Â)°ÇÃàÁ¦ÇѼ±
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á